bpc 157 clinicaltrials gov BPC-157 & The Gut-Brain Axis: A Practitioner's Definitive Review of the Evidence Heal or Harm: Body Protective
Description
It details molecular mechanisms through GLP-1 receptor signaling, cAMP pathways, and neuroendocrine interactions that regulate appetite and glucose metabolism
43 PaulC.BradyD
Specifically, it was reported not to elevate IGF-1 and not to impair glucose tolerance or insulin sensitivity the very liabilities it was engineered to avoid
And in the brain, its helping facilitate neurotransmission, helping improve cognitive function
